Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Alzheimer's disease

Attack on amyloid-β protein

An antibody therapy markedly reduces aggregates of amyloid-β, the hallmark protein of Alzheimer's disease, and might slow cognitive decline in patients. Confirmation of a cognitive benefit would be a game-changer. See Article p.50

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: The amyloid hypothesis.


  1. See all news & views


  1. Selkoe, D. J. & Hardy, J. EMBO Mol. Med. 8, 595–608 (2016).

    CAS  Article  Google Scholar 

  2. Sevigny, J. et al. Nature 537, 50–56 (2016).

    ADS  CAS  Article  Google Scholar 

  3. Haass, C. & Selkoe, D. J. Nature Rev. Mol. Cell Biol. 8, 101–112 (2007).

    CAS  Article  Google Scholar 

  4. Reiman, E. M. et al. Nature Rev. Neurol. 12, 56–61 (2016).

    CAS  Article  Google Scholar 

  5. Fleisher, A. S. et al. JAMA Neurol. 72, 316–324 (2015).

    Article  Google Scholar 

  6. Yu, J. Y. & Watts, R. J. Neurotherapeutics 10, 459–472 (2013).

    Article  Google Scholar 

  7. Sperling, R. A. et al. Alzheimer's Dement. 7, 367–385 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Eric M. Reiman.

Ethics declarations

Competing interests

E.M.R. is a principal investigator of the Alzheimer’s Prevention Initiative (API), which is involved in the evaluation of anti-Aβ and other promising Alzheimer’s prevention therapies.

Related audio

Related links

Related links

Related links in Nature Research

Alzheimer's disease: A protective mutation

Alzheimer's disease: Lost memories found

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Reiman, E. Attack on amyloid-β protein. Nature 537, 36–37 (2016).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing